BioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool

Links shared publicly online about this topic.

  • 1,319
    total visits

BioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool

medicalnewstoday.com —

bioMerieux a world leader in the field of in vitro diagnostics announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective s

View full resource at medicalnewstoday.com

Tags: VRE, Drug, FDA

  • Share

Most Recently Shared on March 13, 2010 at 4:05 am By:

mnt_clinical MNT Clinical Trials

BioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool http://mnt.to/3yQq #clinicaltrials

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Drug Approvals MNT Drug Approvals

Advertisement